Skip to main content
. 2021 May 5;12(3):586–598. doi: 10.1002/jcsm.12705

Table 1.

Participant characteristics

CKD (n = 8767) Non‐CKD (n = 419 553) P value
Age, years 62.8 (5.8) 56.1 (8.1) <0.001
Sex, male, n (%) 4055 (46%) 195 570 (47%) 0.510
Ethnicity
White 8346 (95%) 396 213 (94%) 0.002
Other 421 (5%) 23 340 (6%)
No. of comorbidities
0 1977 (23%) 195 716 (47%) <0.001
1 2942 (34%) 139 696 (33%)
2 2168 (25%) 58 102 (14%)
≥3 1680 (19%) 26 039 (6%)
Albumin, g/L 44.4 (2.9) 45.3 (2.6) <0.001
eGFR, mL/min/1.72 m2a 54.5 (49.0–57.7) 93.3 (84.1–100.5) <0.001
Stage 3a, n (%) 7423 (85%)
Stage 3b, n (%) 1079 (12%)
Stage 4, n (%) 238 (3%)
CRP, mg/L a 1.98 (0.99–4.12) 1.30 (0.64–2.70) <0.001
Haemoglobin, g/dL 13.8 (1.4) 14.2 (1.2) <0.001
Testosterone, nmol/L a 6.0 (1.0–10.8) 5.58 (1.0–11.7) <0.001
HbA1c, mmol/L 39.3 (9.2) 36.0 (6.7) <0.001
Body mass, kg 82.1 (16.4) 78.1 (15.9) <0.001
BMI, kg/m2 29.3 (5.2) 27.4 (4.7) <0.001
Body fat, %
Males 27.2 (5.8) 25.2 (5.8) <0.001
Females 39.1 (6.8) 36.5 (7.0) <0.001
ALM, kg
Males 27.2 (4.2) 27.0 (3.9) 0.013
Females 19.0 (2.7) 18.4 (2.4) <0.001
ALM/height2
Males 8.9 (1.2) 8.7 (1.1) <0.001
Females 7.3 (1.0) 7.0 (0.8) <0.001
ALMBMI
Males 0.93 (0.1) 0.98 (0.1) <0.001
Females 0.66 (0.1) 0.69 (0.1) <0.001
Handgrip strength, kg
Males 38.8 (9.3) 41.9 (9.0) <0.001
Females 23.4 (6.6) 25.2 (6.4) <0.001
Slow walking speed, n (%)
Males 842 (21%) 14 290 (7%) <0.001
Females 882 (19%) 17 058 (8%) <0.001

BMI, body mass index; ALM, appendicular lean mass; CKD, chronic kidney disease; CRP, C‐reactive protein; eGFR, estimated glomerular filtration rate.

a

Median and interquartile range.

Data presented as mean and standard deviation, unless otherwise indicated.

Missing data for these variables can be found in Data S7.